Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
Thailand school shooting toll rises to nine after death of 12-year-old girl
Thousands told to evacuate in British Columbia as wildfire grows
Three killed in Russian strikes in Kyiv region, official says
Typhoon Dolphin hits Japan's Okinawa, China shuts ports ahead of landfall
Spain to establish border controls against Italy amid migration dispute
